Literature DB >> 15782009

Stereotactic radiosurgery for recurrent pleomorphic adenoma invading the skull base--case report--.

Tohru Kamida1, Tatsuya Abe, Ryo Inoue, Hidenori Kobayashi, Masashi Suzuki, Akira Matsumoto.   

Abstract

A 38-year-old man presented with a recurrent pleomorphic adenoma in the parapharyngeal space invading the skull base 19 years after the first operation for a parotid gland tumor. Stereotactic radiotherapy was performed to control the tumor growth using a marginal dose of 8 Gy and maximum dose of 18 Gy with care taken to minimize the dose to nearby structures. The symptoms were reduced within a few months. Magnetic resonance imaging over 5 years showed that the tumor was controlled with no regrowth. Stereotactic radiotherapy is a therapeutic option for the treatment of pleomorphic adenomas.

Entities:  

Mesh:

Year:  2005        PMID: 15782009     DOI: 10.2176/nmc.45.161

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  4 in total

1.  Survival outcomes of patients treated with hypofractionated stereotactic body radiation therapy for parotid gland tumors: a retrospective analysis.

Authors:  Sana D Karam; James W Snider; Hongkun Wang; Margaux Wooster; Christopher Lominska; John Deeken; Kenneth Newkirk; Bruce Davidson; K William Harter
Journal:  Front Oncol       Date:  2012-05-31       Impact factor: 6.244

2.  Delayed cerebral radiation necrosis after neutron beam radiation of a parotid adenocarcinoma: a case report and review of the literature.

Authors:  Christopher S Hong; Hamza N Gokozan; José J Otero; Michael Guiou; J Bradley Elder
Journal:  Case Rep Neurol Med       Date:  2014-09-30

3.  Massive transcranial parotid pleomorphic adenoma: recurrence after 30 years.

Authors:  Graham M Strub; Alexandros Georgolios; Robert S Graham; Celeste N Powers; Daniel H Coelho
Journal:  J Neurol Surg Rep       Date:  2012-10

4.  Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature.

Authors:  Luca Oscar Redaelli de Zinis; Michela Piccioni; Antonino Roberto Antonelli; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-25       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.